Ketamine Providers in Vermont
2 providers across 2 cities
Vermont has 2 ketamine therapy providers across 2 cities. The most common provider types are med spa & aesthetic, pain management clinic. Providers in Vermont commonly treat chronic pain, depression, anxiety. Top cities include Montpelier, White River Junction.
Ketamine Therapy in Vermont
Vermont may be the nation's second-smallest state by population, but it punches above its weight in mental health innovation. The University of Vermont offers one of the country's only accredited Ketamine-Assisted Psychotherapy training certificates, and Blue Cross VT is among the rare private insurers that cover IV ketamine for severe treatment-resistant depression. This directory helps Vermont residents find licensed ketamine providers — from Burlington clinics to telehealth options serving every corner of the Green Mountain State.
Vermont ranks 43rd nationally with 2 ketamine therapy providers, averaging 1 provider per city. The largest provider category is med spa & aesthetic (50% of providers). Montpelier leads the state with 1 provider.
State Regulations
Vermont follows federal DEA Schedule III rules without state-specific ketamine clinic regulations. The Vermont Board of Medical Practice issued a 2024 joint statement on IV therapy clinics emphasizing that only licensed prescribers may prescribe IV products. Vermont enacted Act 126 (2024) creating a Psychedelic Therapy Advisory Working Group that included a ketamine therapy expert. No CPOM doctrine applies.
Insurance & Medicaid Coverage
Vermont's Green Mountain Care (Medicaid) covers Spravato through Blue Cross VT per payment policy CPP_40 (updated May 2025). Blue Cross VT's broader ketamine medical policy (5.01.VT204, updated August 2024) also covers IV ketamine infusion for severe TRD with specific criteria including failure of 4+ antidepressant trials, psychiatrist prescriber, MADRS >=28 or HAM-D >=17, and no substance use disorder.
Telehealth Options
Vermont law (18 V.S.A. SS9361) allows telehealth prescribing after an appropriate patient examination conducted in person or via telemedicine. DEA flexibilities through December 31, 2026 permit ketamine prescribing via telehealth without prior in-person visit.
Cost of Ketamine Therapy
IV ketamine infusions in Vermont typically cost $400–$750 per session. Vermont's small, rural population means limited clinic competition. Burlington-area providers set market pricing similar to New England averages. Oral/sublingual KAP sessions are more affordable alternatives. A standard initial series of 6 infusions runs $2400–$4500. Spravato (esketamine) may be partially or fully covered by insurance.
Mental Health Access
Vermont has 12 active mental health HPSA designations as of December 2025 (HRSA data). The state's small provider base and psychiatrist shortage affect rural areas particularly, though precise 'percent of need met' was not reported by HRSA for Vermont. Vermont has approximately 0.31 ketamine providers per 100,000 residents.
Frequently Asked Questions
- Yes — Blue Cross Blue Shield of Vermont's medical policy 5.01.VT204 covers IV ketamine infusions for treatment-resistant MDD meeting strict criteria: failure of 4+ antidepressants, severe symptoms on a validated scale (MADRS >=28 or HAM-D >=17), psychiatrist prescriber, and no substance use disorder. This is uncommon nationally.
- Vermont passed Act 126 in 2024 creating a Psychedelic Therapy Advisory Working Group. The November 2024 final report did not recommend establishing a state psilocybin program at this time. Ketamine remains the primary legal psychedelic-assisted therapy available in Vermont.
- Yes. Vermont law allows prescribing via telehealth after an appropriate examination which can itself be conducted by telemedicine. DEA flexibilities through December 2026 permit Schedule III ketamine prescribing without a prior in-person visit.